Keywords: generex, oral-lyn, non-inferior, insulin, analogs, us-listed, firm

Generex Oral-lyn non-inferior to insulin analogs

Article | 30 June 2008

Print This

US-listed firm Generex Biotechnology presented strong trial data at the Endocrine Society's 90th annual meeting, held in San Francisco, USA, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in